Mainz, Germany

Tobias Wunberg

This inventor holds 1 USPTO granted patent. Top assignee: Aventis Pharma Deutschland, Gmbh. Active years: 2004.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Tobias Wunberg. Retrieved from https://idiyas.com/inventor/tobias-wunberg-ugymvxum

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 2004

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Tobias Wunberg: An Innovative Mind in Pharmaceuticals

Introduction

Tobias Wunberg, a prominent inventor located in Mainz, Germany, is known for his significant contributions to the pharmaceutical industry. He has developed innovative compounds that pave the way for new medical applications.

Latest Patents

Wunberg holds a patent for "Substituted tetrahydropyrane derivatives, method for producing same, their use as medicine or diagnostic agent, as well as medicine containing same." This patent reflects his commitment to advancing medicinal chemistry and improving healthcare outcomes.

Career Highlights

Currently, Tobias Wunberg works at Aventis Pharma Deutschland GmbH, where he continues to push the boundaries of pharmaceutical research. His tenure at the company has positioned him as a valuable asset in the development of new therapeutic solutions.

Collaborations

In his professional journey, Wunberg has collaborated with notable colleagues such as Wolfgang Schmidt and Stephan Henke. These partnerships have amplified his innovative efforts, fostering an environment of shared knowledge and creativity.

Conclusion

Tobias Wunberg exemplifies the spirit of innovation in the pharmaceutical sector. With his unique patent and collaborative spirit, he continues to make valuable contributions to medicine and diagnostics, promising advancements that benefit society as a whole.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…